SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Who May Qualify: - ≥ 18 years old and; - Patients treated with SUPRAFLEX CRUZ according to routine hospital practice and following instructions for use - Patients with multivessel coronary artery disease (understood as that which affects more than one territory of the major epicardial coronary arteries - anterior descending, circumflex, right coronary artery) who is treated with more than 1 stent under study in lesions located in more than 1 of the aforementioned arteries. - Substudy: Patients with Ejection Fraction \<45% by Echocardiography - willing to sign a consent form signed Who Should NOT Join This Trial: - Not meet inclusion criteria - Contraindication for antiplatelet treatment - Patient life expectancy less than 12 months Always talk to your doctor about whether this trial is right for you.